Current situation of shared decision making in osteoporosis: A comprehensive literature review of patient decision aids and decision drivers

被引:4
作者
Nogues, Xavier [1 ]
Carbonell, Maria Cristina [2 ]
Canals, Laura [3 ]
Lizan, Luis [4 ,5 ,7 ]
Palacios, Santiago [6 ]
机构
[1] Univ Autonoma Barcelona, Inst Invest Hosp del Mar IMIM, Ctr Invest Biomed Red Fragil & Envejecimiento Salu, Internal Med Dept, Barcelona, Spain
[2] Univ Barcelona, Atencio Primaria Barcelona, Dept Med, Grp GREMPAL,Inst Catala Salut ICS, Barcelona, Spain
[3] Amgen Europe, Dept Med, Risch Rotkreuz, Switzerland
[4] Outcomes 10, Dept Outcomes Res, Castellon Plana, Castellon de la Plana, Spain
[5] Univ Jaume 1, Dept Med, Castellon De Plana, Spain
[6] Inst Palacios Salud Mujer, Madrid, Spain
[7] Univ Jaume 1, Castellon de la Plana 12071, Edificio ESPAIT, Spain
关键词
osteoporosis; patient decision aids; review; share decision-making; POSTMENOPAUSAL WOMEN; DRUG-TREATMENT; PATIENTS PREFERENCES; CHOICE; SATISFACTION; MEDICATION; BISPHOSPHONATES; PERCEPTIONS; PERSISTENCE; ATTRIBUTES;
D O I
10.1002/hsr2.849
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background and AimsOsteoporosis is a systemic skeletal disease characterized by low bone mass and microstructural deterioration of bone tissues, resulting in bone fragility and increased fracture risk. It is the most common bone-related disease in the population. However, the proportion of patients who start treatment but discontinue it during the first year is very high (around 50%). Endeavors are made to promote patient participation in treatment by implementing patient decision aids (PDA), whose function is to help the patient make disease-related decisions. We aim to summarize the characteristics of the currently available PDA for osteoporosis, as well as deciding factors. MethodsComprehensive review of the literature. ResultsCurrently, eleven PDAs can be found for osteoporosis. These PDA have different characteristics or options such as information about treatments tailored to patient needs, graphic information of the results (to facilitate understanding), personal histories (learning), tests to check the knowledge acquired, provision of evidence, clinical practice guidelines or a final summary to share with their doctor. Only five of these PDAs can be considered complete since they provide relevant disease information and therapeutic options to the patient, promote patient's reflection and foment patient-physician discussion. ConclusionsThis study provides an update on the current state of decision making on osteoporosis and available PDA, which can help engage the patient through shared decision-making by considering, among other things, patient preferences. Physicians should consider PDA, as it may promote adherence and effectiveness of treatment.
引用
收藏
页数:10
相关论文
共 77 条
  • [1] Agoritsas T., 2015, BMJ-BRIT MED J, V350, P1
  • [2] Secular Trends in Hip Fractures Worldwide: Opposing Trends East Versus West
    Ballane, Ghada
    Cauley, Jane A.
    Luckey, Marjorie M.
    El-Hajj Fuleihan, Ghada
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 (08) : 1745 - 1755
  • [3] Women's Values and Preferences Regarding Osteoporosis Treatments: A Systematic Review
    Barrionuevo, Patricia
    Gionfriddo, Michael R.
    Castaneda-Guarderas, Ana
    Zeballos-Palacios, Claudia
    Bora, Pavithra
    Mohammed, Khaled
    Benkhadra, Khalid
    Sarigianni, Maria
    Murad, Mohammad Hassan
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (05) : 1631 - 1636
  • [4] Shared Decision Making - The Pinnacle of Patient-Centered Care
    Barry, Michael J.
    Edgman-Levitan, Susan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (09) : 780 - 781
  • [5] Bisphosphonate therapy for osteoporosis: combining optimal fracture risk reduction with patient preference
    Beard, Mary K.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (01) : 141 - 147
  • [6] Bekker H., 2013, UPDATE INT PATIENT D, V2012
  • [7] Patient Satisfaction in Postmenopausal Women Treated with a Weekly Bisphosphonate Transitioned to Once-Monthly Ibandronate
    Bonnick, Sydney Lou
    Silverman, Stuart
    Tanner, S. Bobo
    Martens, Mark
    Bachmann, Gloria
    Kohles, Joseph D.
    Civitelli, Roberto
    [J]. JOURNAL OF WOMENS HEALTH, 2009, 18 (07) : 935 - 943
  • [8] AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2020 UPDATE EXECUTIVE SUMMARY
    Camacho, Pauline M.
    Petak, Steven M.
    Binkley, Neil
    Diab, Dima L.
    Eldeiry, Leslie S.
    Farooki, Azeez
    Harris, Steven T.
    Hurley, Daniel L.
    Kelly, Jennifer
    Lewiecki, E. Michael
    Pessah-Pollack, Rachel
    McClung, Michael
    Wimalawansa, Sunil J.
    Watts, Nelson B.
    [J]. ENDOCRINE PRACTICE, 2020, 26 (05) : 564 - 570
  • [9] Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model
    Charles, C
    Gafni, A
    Whelan, T
    [J]. SOCIAL SCIENCE & MEDICINE, 1999, 49 (05) : 651 - 661
  • [10] Antiresorptive therapies for osteoporosis: a clinical overview
    Chen, Jian Sheng
    Sambrook, Philip N.
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2012, 8 (02) : 81 - 91